These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20855206)

  • 1. Synthesis and antiproliferative evaluation of N,N-disubstituted-N'-[1-aryl-1H-pyrazol-5-yl]-methnimidamides.
    Cheng KM; Huang YY; Huang JJ; Kaneko K; Kimura M; Takayama H; Juang SH; Wong FF
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6781-4. PubMed ID: 20855206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
    Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
    Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antiproliferative, and antiplatelet activities of oxime- and amide-containing quinolin-2(1H)-one derivatives.
    Chen IL; Chang KM; Miaw CL; Liao CH; Chen JJ; Wang TC
    Bioorg Med Chem; 2007 Oct; 15(20):6527-34. PubMed ID: 17689252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, crystal structure and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives.
    Zheng LW; Zhu J; Zhao BX; Huang YH; Ding J; Miao JY
    Eur J Med Chem; 2010 Dec; 45(12):5792-9. PubMed ID: 20947221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5-carbohydrazide derivatives.
    Zhang D; Wang G; Zhao G; Xu W; Huo L
    Eur J Med Chem; 2011 Dec; 46(12):5868-77. PubMed ID: 22000925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,5-Diphenyl-1H-pyrazole derivatives. IV--N,N-disubstituted 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamides and 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamines with sedative, platelet antiaggregating and local anesthetic activities.
    Bondavalli F; Bruno O; Ranise A; Schenone P; Losasso C; Donnoli D; Stella L; Marmo E
    Farmaco; 1990 Feb; 45(2):137-46. PubMed ID: 2133991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cytotoxicity evaluation of 1-[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]-3-aryl-1H-pyrazole-5-carboxylic acid derivatives.
    Nagarapu L; Gaikwad HK; Sarikonda K; Mateti J; Bantu R; Raghu PS; Manda KM; Kalvendi SV
    Eur J Med Chem; 2010 Nov; 45(11):4720-5. PubMed ID: 20817327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents.
    Bekhit AA; Ashour HM; Abdel Ghany YS; Bekhit Ael-D; Baraka A
    Eur J Med Chem; 2008 Mar; 43(3):456-63. PubMed ID: 17532544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates from biologically active 1-aryl-2-hydrazinoimidazolines: synthesis, crystal structure and antiproliferative activity.
    Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
    Eur J Med Chem; 2006 Dec; 41(12):1373-84. PubMed ID: 16996655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses of phenylpyrazolodiazepin-7-ones as conformationally rigid analogs of aminopyrazole amide scaffold and their antiproliferative effects on cancer cells.
    Kim H; Kim M; Lee J; Yu H; Hah JM
    Bioorg Med Chem; 2011 Nov; 19(22):6760-7. PubMed ID: 22014755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facile synthesis of fused pyrazolo[1,5-a]pyrimidinepyrazolo [1,5-a]triazines and N-sulphonamidopyrazoles as antiinflammatory.
    Fathalla OA; Zaki ME; Swelam SA; Nofal SM; el-Eraky WI
    Acta Pol Pharm; 2003; 60(1):51-60. PubMed ID: 12848368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives.
    Congiu C; Onnis V; Vesci L; Castorina M; Pisano C
    Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiproliferative evaluation of amide-containing flavone and isoflavone derivatives.
    Chen IL; Chen JY; Shieh PC; Chen JJ; Lee CH; Juang SH; Wang TC
    Bioorg Med Chem; 2008 Aug; 16(16):7639-45. PubMed ID: 18662883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors.
    Lin R; Chiu G; Yu Y; Connolly PJ; Li S; Lu Y; Adams M; Fuentes-Pesquera AR; Emanuel SL; Greenberger LM
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4557-61. PubMed ID: 17574416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiproliferative activities of N-(naphthalen-2-yl)acetamide and N-(substituted phenyl)acetamide bearing quinolin-2(1H)-one and 3,4-dihydroquinolin-2(1H)-one derivatives.
    Chen IL; Chen JJ; Lin YC; Peng CT; Juang SH; Wang TC
    Eur J Med Chem; 2013 Jan; 59():227-34. PubMed ID: 23229058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,5-Diphenyl-1H-pyrazole derivatives. VIII. N-substituted 3-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)-propanamides, -propanamines and 2-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)ethanamines with platelet antiaggregating, hypotensive, antiarrhythmic and other activities.
    Bruno O; Bondavalli F; Ranise A; Schenone P; Cenicola ML; Donnoli D; Filippelli W; Losasso C; Costantino M; Marmo E
    Farmaco; 1991 Mar; 46(3):477-99. PubMed ID: 1892504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
    Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.
    Price S; Bordogna W; Bull RJ; Clark DE; Crackett PH; Dyke HJ; Gill M; Harris NV; Gorski J; Lloyd J; Lockey PM; Mullett J; Roach AG; Roussel F; White AB
    Bioorg Med Chem Lett; 2007 Jan; 17(2):370-5. PubMed ID: 17095213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of some pyrazolinylpyridines and pyrazolylpyridines.
    Singh T; Sharma S; Srivastava VK; Kumar A
    Arch Pharm (Weinheim); 2006 Jan; 339(1):24-31. PubMed ID: 16411173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiproliferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives.
    Popowycz F; Schneider C; Debonis S; Skoufias DA; Kozielski F; Galmarini CM; Joseph B
    Bioorg Med Chem; 2009 May; 17(9):3471-8. PubMed ID: 19349183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.